Athira Pharma Inc. (ATHA) Appoints Grant Pickering to its Board

Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced the appointment of Grant Pickering to its Board of Directors. Mr. Pickering is Chief Executive Officer, co-founder and member of the Board of Directors at Vaxcyte, Inc. (NASDAQ: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases.

“Grant is an accomplished life sciences leader with considerable experience across all stages of development and commercialization of new medicines,” said Mark Litton, Ph.D., President and Chief Executive Officer at Athira. “His deep experience in the biopharma industry provides a valuable resource to Athira as we advance the development of innovative therapies for neurological diseases.”

Mr. Pickering has over 30 years of experience across vaccines and immunotherapeutic drug development and commercialization and has led the successful formation and financing of multiple platform companies.

Mr. Pickering commented, “Athira’s lead candidate ATH-1017 and drug discovery platform offers an innovative approach to the development of therapies designed to improve the outlook for those suffering from a range of neurological diseases, including Alzheimer’s Disease. I look forward to working with my fellow Board members and company management as we continue to advance Athira’s innovative pipeline.”

Mr. Pickering previously served as CEO of Mymetics Corporation and Juvaris BioTherapeutics. Prior to Juvaris, Mr. Pickering served as Senior Vice President, Operations at Dendreon Corporation and led marketing and business development for Algos Pharmaceutical Corporation. Mr. Pickering began his career at Glaxo and Johnson & Johnson in sales, marketing, and clinical research roles. Mr. Pickering earned his BS degree in marketing from The Pennsylvania State University and his MBA from Georgetown University with high honors.

You May Also Be Interested In

• Virtus Investment Partners names Jack Boyce to its board
• Hertz Global amends voting agreement with CK Amarillo after lawsuit
• Blue Moon Metals cleared to build at Nevada tungsten project